Quest for the right Drug

|
עמוד הבית / פלסמה-ליט 148 (pH 7.4) / מידע מעלון לרופא

פלסמה-ליט 148 (pH 7.4) PLASMA-LYTE 148 (pH 7.4) (MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM ACETATE TRIHYDRATE, SODIUM CHLORIDE, SODIUM GLUCONATE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

תוך-ורידי : I.V

צורת מינון:

תמיסה לאינפוזיה : SOLUTION FOR INFUSION

Posology : מינונים

4.2        Posology and method of administration

Plasma-Lyte® 148 (pH 7.4) is compatible with blood or blood components. It may be administered prior to or following the infusion of blood through the same administration set (i.e., as a priming solution), added to or infused concurrently with blood components, or used as a diluent in the transfusion of packed erythrocytes. Plasma-Lyte® 148 (pH 7.4) and 0.9% Sodium Chloride Injection, USP are equally compatible with blood or blood components.

All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile and nonpyrogenic equipment.
As directed by a physician. Dosage, rate and duration of administration are to be individualized and dependent upon the indication for use, the patient’s age, weight, concomitant treatment and clinical condition of the patient as well as laboratory determinations.

After opening the container, the contents should be used immediately and should not be stored for a subsequent infusion. Do not reconnect any partially used containers.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

Do not administer unless the solution is clear and seal is intact.

Additives may be incompatible with Plasma-Lyte® 148 (pH 7.4). As with all parenteral solutions, compatibility of the additives with the solution must be assessed before addition.
Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Plasma-Lyte® 148 (pH 7.4) is appropriate. After addition, check for a possible color change and/or the appearance of precipitates, insoluble complexes or crystals.
The instructions for use of the medication to be added and other relevant literature must be consulted. Additives known or determined to be incompatible must not be used. When introducing additives to Plasma-Lyte® 148 (pH 7.4), aseptic technique must be used. Mix the solution thoroughly when additives have been introduced. Do not store solutions containing additives.

שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל לא צוין
הגבלות לא צוין

בעל רישום

TEVA ISRAEL LTD

רישום

163 51 35362 01

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

10.03.22 - עלון לרופא 22.12.23 - עלון לרופא

עלון מידע לצרכן

לתרופה במאגר משרד הבריאות

פלסמה-ליט 148 (pH 7.4)

קישורים נוספים

RxList WebMD Drugs.com